0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Adoptive Cell Transfer Therapy Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-22K13612
Home | Market Reports | Health| Reproductive Health
Global Adoptive Cell Transfer Therapy Market Research Report 2023
BUY CHAPTERS

Global Adoptive Cell Transfer Therapy Market Research Report 2025

Code: QYRE-Auto-22K13612
Report
September 2025
Pages:118
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Adoptive Cell Transfer Therapy Market

The global market for Adoptive Cell Transfer Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Adoptive Cell Transfer Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Adoptive Cell Transfer Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Adoptive Cell Transfer Therapy in Acute Lymphocytic Leukemia is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Adoptive Cell Transfer Therapy include Novartis AG, Kite Pharma, Pfizer, Juno Therapeutics, Celgene Corporation, CARsgen Therapeutics, Sorrento Therapeutics, Legend Biotech, Atara Biotherapeutics, Aurora Biopharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Adoptive Cell Transfer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adoptive Cell Transfer Therapy.
The Adoptive Cell Transfer Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Adoptive Cell Transfer Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adoptive Cell Transfer Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Adoptive Cell Transfer Therapy Market Report

Report Metric Details
Report Name Adoptive Cell Transfer Therapy Market
Segment by Type
  • NK
  • LAK
  • DC
  • CIK
  • CTL
  • TIL
  • TCR-T
  • CAR-T
Segment by Application
  • Acute Lymphocytic Leukemia
  • NHL
  • Melanoma
  • Bladder Cancer
  • Lung Cancer
  • Head and Neck Cancer
  • Multiple Myeloma
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis AG, Kite Pharma, Pfizer, Juno Therapeutics, Celgene Corporation, CARsgen Therapeutics, Sorrento Therapeutics, Legend Biotech, Atara Biotherapeutics, Aurora Biopharma, Autolus Therapeutics PLC, Bluebird, Carina Biotech, Athenex, Xiangxue Pharmaceutical (Xiangxue Precision), Hengrui Yuanzheng, Eureka Therapeutics, WuXi Juno, Shenzhen Inno Immunity, Shenzhen Binde Bio, Kerui Bio, Adaptimmune, Altor Bioscience Corporation, Cellectis, Takara Bio, Unum Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Adoptive Cell Transfer Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Adoptive Cell Transfer Therapy Market report?

Ans: The main players in the Adoptive Cell Transfer Therapy Market are Novartis AG, Kite Pharma, Pfizer, Juno Therapeutics, Celgene Corporation, CARsgen Therapeutics, Sorrento Therapeutics, Legend Biotech, Atara Biotherapeutics, Aurora Biopharma, Autolus Therapeutics PLC, Bluebird, Carina Biotech, Athenex, Xiangxue Pharmaceutical (Xiangxue Precision), Hengrui Yuanzheng, Eureka Therapeutics, WuXi Juno, Shenzhen Inno Immunity, Shenzhen Binde Bio, Kerui Bio, Adaptimmune, Altor Bioscience Corporation, Cellectis, Takara Bio, Unum Therapeutics

What are the Application segmentation covered in the Adoptive Cell Transfer Therapy Market report?

Ans: The Applications covered in the Adoptive Cell Transfer Therapy Market report are Acute Lymphocytic Leukemia, NHL, Melanoma, Bladder Cancer, Lung Cancer, Head and Neck Cancer, Multiple Myeloma, Other

What are the Type segmentation covered in the Adoptive Cell Transfer Therapy Market report?

Ans: The Types covered in the Adoptive Cell Transfer Therapy Market report are NK, LAK, DC, CIK, CTL, TIL, TCR-T, CAR-T

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adoptive Cell Transfer Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 NK
1.2.3 LAK
1.2.4 DC
1.2.5 CIK
1.2.6 CTL
1.2.7 TIL
1.2.8 TCR-T
1.2.9 CAR-T
1.3 Market by Application
1.3.1 Global Adoptive Cell Transfer Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Acute Lymphocytic Leukemia
1.3.3 NHL
1.3.4 Melanoma
1.3.5 Bladder Cancer
1.3.6 Lung Cancer
1.3.7 Head and Neck Cancer
1.3.8 Multiple Myeloma
1.3.9 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adoptive Cell Transfer Therapy Market Perspective (2020-2031)
2.2 Global Adoptive Cell Transfer Therapy Growth Trends by Region
2.2.1 Global Adoptive Cell Transfer Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Adoptive Cell Transfer Therapy Historic Market Size by Region (2020-2025)
2.2.3 Adoptive Cell Transfer Therapy Forecasted Market Size by Region (2026-2031)
2.3 Adoptive Cell Transfer Therapy Market Dynamics
2.3.1 Adoptive Cell Transfer Therapy Industry Trends
2.3.2 Adoptive Cell Transfer Therapy Market Drivers
2.3.3 Adoptive Cell Transfer Therapy Market Challenges
2.3.4 Adoptive Cell Transfer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adoptive Cell Transfer Therapy Players by Revenue
3.1.1 Global Top Adoptive Cell Transfer Therapy Players by Revenue (2020-2025)
3.1.2 Global Adoptive Cell Transfer Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Adoptive Cell Transfer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Adoptive Cell Transfer Therapy Revenue
3.4 Global Adoptive Cell Transfer Therapy Market Concentration Ratio
3.4.1 Global Adoptive Cell Transfer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cell Transfer Therapy Revenue in 2024
3.5 Global Key Players of Adoptive Cell Transfer Therapy Head office and Area Served
3.6 Global Key Players of Adoptive Cell Transfer Therapy, Product and Application
3.7 Global Key Players of Adoptive Cell Transfer Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Adoptive Cell Transfer Therapy Breakdown Data by Type
4.1 Global Adoptive Cell Transfer Therapy Historic Market Size by Type (2020-2025)
4.2 Global Adoptive Cell Transfer Therapy Forecasted Market Size by Type (2026-2031)
5 Adoptive Cell Transfer Therapy Breakdown Data by Application
5.1 Global Adoptive Cell Transfer Therapy Historic Market Size by Application (2020-2025)
5.2 Global Adoptive Cell Transfer Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Adoptive Cell Transfer Therapy Market Size (2020-2031)
6.2 North America Adoptive Cell Transfer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Adoptive Cell Transfer Therapy Market Size by Country (2020-2025)
6.4 North America Adoptive Cell Transfer Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Adoptive Cell Transfer Therapy Market Size (2020-2031)
7.2 Europe Adoptive Cell Transfer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Adoptive Cell Transfer Therapy Market Size by Country (2020-2025)
7.4 Europe Adoptive Cell Transfer Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adoptive Cell Transfer Therapy Market Size (2020-2031)
8.2 Asia-Pacific Adoptive Cell Transfer Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Adoptive Cell Transfer Therapy Market Size (2020-2031)
9.2 Latin America Adoptive Cell Transfer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Adoptive Cell Transfer Therapy Market Size by Country (2020-2025)
9.4 Latin America Adoptive Cell Transfer Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adoptive Cell Transfer Therapy Market Size (2020-2031)
10.2 Middle East & Africa Adoptive Cell Transfer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Adoptive Cell Transfer Therapy Introduction
11.1.4 Novartis AG Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.1.5 Novartis AG Recent Development
11.2 Kite Pharma
11.2.1 Kite Pharma Company Details
11.2.2 Kite Pharma Business Overview
11.2.3 Kite Pharma Adoptive Cell Transfer Therapy Introduction
11.2.4 Kite Pharma Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.2.5 Kite Pharma Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Adoptive Cell Transfer Therapy Introduction
11.3.4 Pfizer Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.3.5 Pfizer Recent Development
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Details
11.4.2 Juno Therapeutics Business Overview
11.4.3 Juno Therapeutics Adoptive Cell Transfer Therapy Introduction
11.4.4 Juno Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.4.5 Juno Therapeutics Recent Development
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Details
11.5.2 Celgene Corporation Business Overview
11.5.3 Celgene Corporation Adoptive Cell Transfer Therapy Introduction
11.5.4 Celgene Corporation Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.5.5 Celgene Corporation Recent Development
11.6 CARsgen Therapeutics
11.6.1 CARsgen Therapeutics Company Details
11.6.2 CARsgen Therapeutics Business Overview
11.6.3 CARsgen Therapeutics Adoptive Cell Transfer Therapy Introduction
11.6.4 CARsgen Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.6.5 CARsgen Therapeutics Recent Development
11.7 Sorrento Therapeutics
11.7.1 Sorrento Therapeutics Company Details
11.7.2 Sorrento Therapeutics Business Overview
11.7.3 Sorrento Therapeutics Adoptive Cell Transfer Therapy Introduction
11.7.4 Sorrento Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.7.5 Sorrento Therapeutics Recent Development
11.8 Legend Biotech
11.8.1 Legend Biotech Company Details
11.8.2 Legend Biotech Business Overview
11.8.3 Legend Biotech Adoptive Cell Transfer Therapy Introduction
11.8.4 Legend Biotech Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.8.5 Legend Biotech Recent Development
11.9 Atara Biotherapeutics
11.9.1 Atara Biotherapeutics Company Details
11.9.2 Atara Biotherapeutics Business Overview
11.9.3 Atara Biotherapeutics Adoptive Cell Transfer Therapy Introduction
11.9.4 Atara Biotherapeutics Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.9.5 Atara Biotherapeutics Recent Development
11.10 Aurora Biopharma
11.10.1 Aurora Biopharma Company Details
11.10.2 Aurora Biopharma Business Overview
11.10.3 Aurora Biopharma Adoptive Cell Transfer Therapy Introduction
11.10.4 Aurora Biopharma Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.10.5 Aurora Biopharma Recent Development
11.11 Autolus Therapeutics PLC
11.11.1 Autolus Therapeutics PLC Company Details
11.11.2 Autolus Therapeutics PLC Business Overview
11.11.3 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Introduction
11.11.4 Autolus Therapeutics PLC Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.11.5 Autolus Therapeutics PLC Recent Development
11.12 Bluebird
11.12.1 Bluebird Company Details
11.12.2 Bluebird Business Overview
11.12.3 Bluebird Adoptive Cell Transfer Therapy Introduction
11.12.4 Bluebird Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.12.5 Bluebird Recent Development
11.13 Carina Biotech
11.13.1 Carina Biotech Company Details
11.13.2 Carina Biotech Business Overview
11.13.3 Carina Biotech Adoptive Cell Transfer Therapy Introduction
11.13.4 Carina Biotech Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.13.5 Carina Biotech Recent Development
11.14 Athenex
11.14.1 Athenex Company Details
11.14.2 Athenex Business Overview
11.14.3 Athenex Adoptive Cell Transfer Therapy Introduction
11.14.4 Athenex Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.14.5 Athenex Recent Development
11.15 Xiangxue Pharmaceutical (Xiangxue Precision)
11.15.1 Xiangxue Pharmaceutical (Xiangxue Precision) Company Details
11.15.2 Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview
11.15.3 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Introduction
11.15.4 Xiangxue Pharmaceutical (Xiangxue Precision) Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.15.5 Xiangxue Pharmaceutical (Xiangxue Precision) Recent Development
11.16 Hengrui Yuanzheng
11.16.1 Hengrui Yuanzheng Company Details
11.16.2 Hengrui Yuanzheng Business Overview
11.16.3 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Introduction
11.16.4 Hengrui Yuanzheng Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.16.5 Hengrui Yuanzheng Recent Development
11.17 Eureka Therapeutics
11.17.1 Eureka Therapeutics Company Details
11.17.2 Eureka Therapeutics Business Overview
11.17.3 Eureka Therapeutics Adoptive Cell Transfer Therapy Introduction
11.17.4 Eureka Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.17.5 Eureka Therapeutics Recent Development
11.18 WuXi Juno
11.18.1 WuXi Juno Company Details
11.18.2 WuXi Juno Business Overview
11.18.3 WuXi Juno Adoptive Cell Transfer Therapy Introduction
11.18.4 WuXi Juno Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.18.5 WuXi Juno Recent Development
11.19 Shenzhen Inno Immunity
11.19.1 Shenzhen Inno Immunity Company Details
11.19.2 Shenzhen Inno Immunity Business Overview
11.19.3 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Introduction
11.19.4 Shenzhen Inno Immunity Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.19.5 Shenzhen Inno Immunity Recent Development
11.20 Shenzhen Binde Bio
11.20.1 Shenzhen Binde Bio Company Details
11.20.2 Shenzhen Binde Bio Business Overview
11.20.3 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Introduction
11.20.4 Shenzhen Binde Bio Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.20.5 Shenzhen Binde Bio Recent Development
11.21 Kerui Bio
11.21.1 Kerui Bio Company Details
11.21.2 Kerui Bio Business Overview
11.21.3 Kerui Bio Adoptive Cell Transfer Therapy Introduction
11.21.4 Kerui Bio Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.21.5 Kerui Bio Recent Development
11.22 Adaptimmune
11.22.1 Adaptimmune Company Details
11.22.2 Adaptimmune Business Overview
11.22.3 Adaptimmune Adoptive Cell Transfer Therapy Introduction
11.22.4 Adaptimmune Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.22.5 Adaptimmune Recent Development
11.23 Altor Bioscience Corporation
11.23.1 Altor Bioscience Corporation Company Details
11.23.2 Altor Bioscience Corporation Business Overview
11.23.3 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Introduction
11.23.4 Altor Bioscience Corporation Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.23.5 Altor Bioscience Corporation Recent Development
11.24 Cellectis
11.24.1 Cellectis Company Details
11.24.2 Cellectis Business Overview
11.24.3 Cellectis Adoptive Cell Transfer Therapy Introduction
11.24.4 Cellectis Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.24.5 Cellectis Recent Development
11.25 Takara Bio
11.25.1 Takara Bio Company Details
11.25.2 Takara Bio Business Overview
11.25.3 Takara Bio Adoptive Cell Transfer Therapy Introduction
11.25.4 Takara Bio Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.25.5 Takara Bio Recent Development
11.26 Unum Therapeutics
11.26.1 Unum Therapeutics Company Details
11.26.2 Unum Therapeutics Business Overview
11.26.3 Unum Therapeutics Adoptive Cell Transfer Therapy Introduction
11.26.4 Unum Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2020-2025)
11.26.5 Unum Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Adoptive Cell Transfer Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of NK
 Table 3. Key Players of LAK
 Table 4. Key Players of DC
 Table 5. Key Players of CIK
 Table 6. Key Players of CTL
 Table 7. Key Players of TIL
 Table 8. Key Players of TCR-T
 Table 9. Global Adoptive Cell Transfer Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Adoptive Cell Transfer Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global Adoptive Cell Transfer Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global Adoptive Cell Transfer Therapy Market Share by Region (2020-2025)
 Table 13. Global Adoptive Cell Transfer Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global Adoptive Cell Transfer Therapy Market Share by Region (2026-2031)
 Table 15. Adoptive Cell Transfer Therapy Market Trends
 Table 16. Adoptive Cell Transfer Therapy Market Drivers
 Table 17. Adoptive Cell Transfer Therapy Market Challenges
 Table 18. Adoptive Cell Transfer Therapy Market Restraints
 Table 19. Global Adoptive Cell Transfer Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global Adoptive Cell Transfer Therapy Market Share by Players (2020-2025)
 Table 21. Global Top Adoptive Cell Transfer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Transfer Therapy as of 2024)
 Table 22. Ranking of Global Top Adoptive Cell Transfer Therapy Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by Adoptive Cell Transfer Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of Adoptive Cell Transfer Therapy, Headquarters and Area Served
 Table 25. Global Key Players of Adoptive Cell Transfer Therapy, Product and Application
 Table 26. Global Key Players of Adoptive Cell Transfer Therapy, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Adoptive Cell Transfer Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global Adoptive Cell Transfer Therapy Revenue Market Share by Type (2020-2025)
 Table 30. Global Adoptive Cell Transfer Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global Adoptive Cell Transfer Therapy Revenue Market Share by Type (2026-2031)
 Table 32. Global Adoptive Cell Transfer Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global Adoptive Cell Transfer Therapy Revenue Market Share by Application (2020-2025)
 Table 34. Global Adoptive Cell Transfer Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global Adoptive Cell Transfer Therapy Revenue Market Share by Application (2026-2031)
 Table 36. North America Adoptive Cell Transfer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America Adoptive Cell Transfer Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America Adoptive Cell Transfer Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe Adoptive Cell Transfer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe Adoptive Cell Transfer Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe Adoptive Cell Transfer Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific Adoptive Cell Transfer Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America Adoptive Cell Transfer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America Adoptive Cell Transfer Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America Adoptive Cell Transfer Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 51. Novartis AG Company Details
 Table 52. Novartis AG Business Overview
 Table 53. Novartis AG Adoptive Cell Transfer Therapy Product
 Table 54. Novartis AG Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 55. Novartis AG Recent Development
 Table 56. Kite Pharma Company Details
 Table 57. Kite Pharma Business Overview
 Table 58. Kite Pharma Adoptive Cell Transfer Therapy Product
 Table 59. Kite Pharma Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 60. Kite Pharma Recent Development
 Table 61. Pfizer Company Details
 Table 62. Pfizer Business Overview
 Table 63. Pfizer Adoptive Cell Transfer Therapy Product
 Table 64. Pfizer Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 65. Pfizer Recent Development
 Table 66. Juno Therapeutics Company Details
 Table 67. Juno Therapeutics Business Overview
 Table 68. Juno Therapeutics Adoptive Cell Transfer Therapy Product
 Table 69. Juno Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 70. Juno Therapeutics Recent Development
 Table 71. Celgene Corporation Company Details
 Table 72. Celgene Corporation Business Overview
 Table 73. Celgene Corporation Adoptive Cell Transfer Therapy Product
 Table 74. Celgene Corporation Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 75. Celgene Corporation Recent Development
 Table 76. CARsgen Therapeutics Company Details
 Table 77. CARsgen Therapeutics Business Overview
 Table 78. CARsgen Therapeutics Adoptive Cell Transfer Therapy Product
 Table 79. CARsgen Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 80. CARsgen Therapeutics Recent Development
 Table 81. Sorrento Therapeutics Company Details
 Table 82. Sorrento Therapeutics Business Overview
 Table 83. Sorrento Therapeutics Adoptive Cell Transfer Therapy Product
 Table 84. Sorrento Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 85. Sorrento Therapeutics Recent Development
 Table 86. Legend Biotech Company Details
 Table 87. Legend Biotech Business Overview
 Table 88. Legend Biotech Adoptive Cell Transfer Therapy Product
 Table 89. Legend Biotech Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 90. Legend Biotech Recent Development
 Table 91. Atara Biotherapeutics Company Details
 Table 92. Atara Biotherapeutics Business Overview
 Table 93. Atara Biotherapeutics Adoptive Cell Transfer Therapy Product
 Table 94. Atara Biotherapeutics Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 95. Atara Biotherapeutics Recent Development
 Table 96. Aurora Biopharma Company Details
 Table 97. Aurora Biopharma Business Overview
 Table 98. Aurora Biopharma Adoptive Cell Transfer Therapy Product
 Table 99. Aurora Biopharma Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 100. Aurora Biopharma Recent Development
 Table 101. Autolus Therapeutics PLC Company Details
 Table 102. Autolus Therapeutics PLC Business Overview
 Table 103. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product
 Table 104. Autolus Therapeutics PLC Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 105. Autolus Therapeutics PLC Recent Development
 Table 106. Bluebird Company Details
 Table 107. Bluebird Business Overview
 Table 108. Bluebird Adoptive Cell Transfer Therapy Product
 Table 109. Bluebird Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 110. Bluebird Recent Development
 Table 111. Carina Biotech Company Details
 Table 112. Carina Biotech Business Overview
 Table 113. Carina Biotech Adoptive Cell Transfer Therapy Product
 Table 114. Carina Biotech Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 115. Carina Biotech Recent Development
 Table 116. Athenex Company Details
 Table 117. Athenex Business Overview
 Table 118. Athenex Adoptive Cell Transfer Therapy Product
 Table 119. Athenex Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 120. Athenex Recent Development
 Table 121. Xiangxue Pharmaceutical (Xiangxue Precision) Company Details
 Table 122. Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview
 Table 123. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product
 Table 124. Xiangxue Pharmaceutical (Xiangxue Precision) Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 125. Xiangxue Pharmaceutical (Xiangxue Precision) Recent Development
 Table 126. Hengrui Yuanzheng Company Details
 Table 127. Hengrui Yuanzheng Business Overview
 Table 128. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product
 Table 129. Hengrui Yuanzheng Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 130. Hengrui Yuanzheng Recent Development
 Table 131. Eureka Therapeutics Company Details
 Table 132. Eureka Therapeutics Business Overview
 Table 133. Eureka Therapeutics Adoptive Cell Transfer Therapy Product
 Table 134. Eureka Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 135. Eureka Therapeutics Recent Development
 Table 136. WuXi Juno Company Details
 Table 137. WuXi Juno Business Overview
 Table 138. WuXi Juno Adoptive Cell Transfer Therapy Product
 Table 139. WuXi Juno Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 140. WuXi Juno Recent Development
 Table 141. Shenzhen Inno Immunity Company Details
 Table 142. Shenzhen Inno Immunity Business Overview
 Table 143. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product
 Table 144. Shenzhen Inno Immunity Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 145. Shenzhen Inno Immunity Recent Development
 Table 146. Shenzhen Binde Bio Company Details
 Table 147. Shenzhen Binde Bio Business Overview
 Table 148. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product
 Table 149. Shenzhen Binde Bio Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 150. Shenzhen Binde Bio Recent Development
 Table 151. Kerui Bio Company Details
 Table 152. Kerui Bio Business Overview
 Table 153. Kerui Bio Adoptive Cell Transfer Therapy Product
 Table 154. Kerui Bio Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 155. Kerui Bio Recent Development
 Table 156. Adaptimmune Company Details
 Table 157. Adaptimmune Business Overview
 Table 158. Adaptimmune Adoptive Cell Transfer Therapy Product
 Table 159. Adaptimmune Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 160. Adaptimmune Recent Development
 Table 161. Altor Bioscience Corporation Company Details
 Table 162. Altor Bioscience Corporation Business Overview
 Table 163. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product
 Table 164. Altor Bioscience Corporation Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 165. Altor Bioscience Corporation Recent Development
 Table 166. Cellectis Company Details
 Table 167. Cellectis Business Overview
 Table 168. Cellectis Adoptive Cell Transfer Therapy Product
 Table 169. Cellectis Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 170. Cellectis Recent Development
 Table 171. Takara Bio Company Details
 Table 172. Takara Bio Business Overview
 Table 173. Takara Bio Adoptive Cell Transfer Therapy Product
 Table 174. Takara Bio Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 175. Takara Bio Recent Development
 Table 176. Unum Therapeutics Company Details
 Table 177. Unum Therapeutics Business Overview
 Table 178. Unum Therapeutics Adoptive Cell Transfer Therapy Product
 Table 179. Unum Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2020-2025) & (US$ Million)
 Table 180. Unum Therapeutics Recent Development
 Table 181. Research Programs/Design for This Report
 Table 182. Key Data Information from Secondary Sources
 Table 183. Key Data Information from Primary Sources
 Table 184. Authors List of This Report


List of Figures
 Figure 1. Adoptive Cell Transfer Therapy Picture
 Figure 2. Global Adoptive Cell Transfer Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Adoptive Cell Transfer Therapy Market Share by Type: 2024 VS 2031
 Figure 4. NK Features
 Figure 5. LAK Features
 Figure 6. DC Features
 Figure 7. CIK Features
 Figure 8. CTL Features
 Figure 9. TIL Features
 Figure 10. TCR-T Features
 Figure 11. CAR-T Features
 Figure 12. Global Adoptive Cell Transfer Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 13. Global Adoptive Cell Transfer Therapy Market Share by Application: 2024 VS 2031
 Figure 14. Acute Lymphocytic Leukemia Case Studies
 Figure 15. NHL Case Studies
 Figure 16. Melanoma Case Studies
 Figure 17. Bladder Cancer Case Studies
 Figure 18. Lung Cancer Case Studies
 Figure 19. Head and Neck Cancer Case Studies
 Figure 20. Multiple Myeloma Case Studies
 Figure 21. Other Case Studies
 Figure 22. Adoptive Cell Transfer Therapy Report Years Considered
 Figure 23. Global Adoptive Cell Transfer Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 24. Global Adoptive Cell Transfer Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 25. Global Adoptive Cell Transfer Therapy Market Share by Region: 2024 VS 2031
 Figure 26. Global Adoptive Cell Transfer Therapy Market Share by Players in 2024
 Figure 27. Global Top Adoptive Cell Transfer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Transfer Therapy as of 2024)
 Figure 28. The Top 10 and 5 Players Market Share by Adoptive Cell Transfer Therapy Revenue in 2024
 Figure 29. North America Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. North America Adoptive Cell Transfer Therapy Market Share by Country (2020-2031)
 Figure 31. United States Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Canada Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Europe Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Europe Adoptive Cell Transfer Therapy Market Share by Country (2020-2031)
 Figure 35. Germany Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. France Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. U.K. Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Italy Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Russia Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Nordic Countries Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Asia-Pacific Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Asia-Pacific Adoptive Cell Transfer Therapy Market Share by Region (2020-2031)
 Figure 43. China Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Japan Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. South Korea Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Southeast Asia Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. India Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Australia Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Latin America Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Latin America Adoptive Cell Transfer Therapy Market Share by Country (2020-2031)
 Figure 51. Mexico Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Brazil Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Middle East & Africa Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. Middle East & Africa Adoptive Cell Transfer Therapy Market Share by Country (2020-2031)
 Figure 55. Turkey Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 57. UAE Adoptive Cell Transfer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 58. Novartis AG Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 59. Kite Pharma Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 60. Pfizer Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 61. Juno Therapeutics Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 62. Celgene Corporation Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 63. CARsgen Therapeutics Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 64. Sorrento Therapeutics Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 65. Legend Biotech Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 66. Atara Biotherapeutics Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 67. Aurora Biopharma Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 68. Autolus Therapeutics PLC Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 69. Bluebird Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 70. Carina Biotech Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 71. Athenex Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 72. Xiangxue Pharmaceutical (Xiangxue Precision) Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 73. Hengrui Yuanzheng Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 74. Eureka Therapeutics Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 75. WuXi Juno Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 76. Shenzhen Inno Immunity Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 77. Shenzhen Binde Bio Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 78. Kerui Bio Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 79. Adaptimmune Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 80. Altor Bioscience Corporation Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 81. Cellectis Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 82. Takara Bio Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 83. Unum Therapeutics Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2020-2025)
 Figure 84. Bottom-up and Top-down Approaches for This Report
 Figure 85. Data Triangulation
 Figure 86. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

RELATED REPORTS

Global Microfluidic in Vitro Diagnostics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24Z19487
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Yohimbe Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34B2983
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Erection Rings Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19V3238
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Sperm Bank Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35F5845
Wed Sep 10 00:00:00 UTC 2025

Add to Cart